ARCHIVES

NCI program announcement available, contract awards listed.

This article is from The Cancer Letter archive.

Vol. 29 No. 42 | November 14, 2003

Download PDF Visit The Full Archive

Related Articles

FDA examining endpoints for approval of cancer therapies, potential departure from survival as the gold standard, Oncology Division Director Richard Pazdur says in interview.

November 7, 2003

Longterm Followup Finds Taxotere Improves Survival

January 25, 2008

Leptin Could Be Indicator Of Breast Cancer Risk

April 25, 2003

In Brief: Phil Web, Former NCI Contracts Official, Dies; Minimal Breast Cancer Workshop Set

February 15, 1980

FDA Offers Grants For Conferences

May 1, 1987

ORI Instructs NSAB to Prepare for Investigation

April 19, 1996